Get the Stockscreener App
4.25
24.27%
0.83
After Hours:
4.09
-0.16
-3.76%
Mangoceuticals Inc Stock (MGRX) Forecast
The Mangoceuticals Inc (MGRX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.134, representing a -96.85% decrease from the current price of $4.25. The highest analyst price target is $0.117, and the lowest is $0.1509.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MGRX Price Target
Average 0.7483
(-82.39% Downside)
Is Mangoceuticals Inc (MGRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 81.46 | Sell |
| STOCH(9,6) | 90.29 | Sell |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.2487 | Buy |
| ADX(14) | 23.35 | Neutral |
| William %R | -8.2418 | Sell |
| CCI(14) | 272.16 | Buy |
Buy: 2
Sell: 4
Neutral: 1
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.1077
Buy
|
3.2639
Buy
|
| MA20 |
2.9198
Buy
|
3.0269
Buy
|
| MA50 |
2.6869
Buy
|
2.838
Buy
|
| MA100 |
2.7916
Buy
|
3.0405
Buy
|
| MA200 |
3.8564
Buy
|
3.7772
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, MGRX could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 4 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on MGRX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 81.46 indicates that MGRX is overbought. This suggests that MGRX price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 90.29 indicates that MGRX is oversold. This means that MGRX price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that MGRX is oversold. This suggests that MGRX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.35 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 272.16 indicates that MGRX is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term MGRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Mangoceuticals Inc financial reports and earnings history, Mangoceuticals Inc (MGRX) stock could reach $2.0078 by 2030, $6.8429 by 2040 and $13.13 by 2050. See the projected annual prices until 2050 of the Mangoceuticals Inc stock below:
- Mangoceuticals Inc (MGRX) is expected to reach an average price of $3.9768 in 2035, with a high prediction of $4.3107 and a low estimate of $4.3444. This indicates an $-6.43% rise from the last recorded price of $4.25.
- Mangoceuticals Inc (MGRX) stock is projected to chart a bullish course in 2040, with an average price target of $6.7709, representing an $59.32% surge from its current level. The forecast ranges from a conservative $6.8355 to a sky-high $6.8429.
- Our analysts predict Mangoceuticals Inc (MGRX) to jump 120.95% by 2045, soaring from $9.43 to an average price of $9.3903, potentially reaching $9.8293. While $9.43 is the low estimate, the potential upside is significant.
- Mangoceuticals Inc (MGRX) stock is expected to climb by 2050, reaching an average of $12.51, a $194.44% jump from its current level. However, a wide range of estimates exists, with high and low targets of $13.13 and $12.61, respectively, highlighting the market's uncertainty.
Mangoceuticals Inc Stock (MGRX) Year by Year Forecast
Mangoceuticals Inc Stock (MGRX) Price Forecast for 2025
Mangoceuticals Inc Stock (MGRX) is expected to reach an average price of $0.7483 in 2025, with a high prediction of $1.4911 and a low estimate of $0.00554. This indicates an -82.39% fall from the last recorded price of $4.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $0.1019 | $0.1509 | $0.117 | -97.60% |
| April, 2025 | $0.0176 | $0.00554 | $0.1301 | -99.59% |
| May, 2025 | $0.0867 | $0.098 | $0.0957 | -97.96% |
| June, 2025 | $0.0577 | $0.0916 | $0.0981 | -98.64% |
| July, 2025 | $0.0193 | $0.00707 | $0.0658 | -99.54% |
| August, 2025 | $0.6793 | $0.0184 | $0.7999 | -84.02% |
| September, 2025 | $0.4379 | $0.5279 | $1.4911 | -89.70% |
| October, 2025 | $0.00387 | $0.3761 | $0.8539 | -99.91% |
| November, 2025 | $0.2253 | $0.0246 | $0.5046 | -94.70% |
| December, 2025 | $0.043 | $0.054 | $0.546 | -98.99% |
Mangoceuticals Inc Stock (MGRX) Price Forecast for 2026
The predicted value for Mangoceuticals Inc (MGRX) in 2026 is set at an average of $0.7274. Estimates vary from a peak of $1.3339 to a trough of $0.1208, indicating an -82.89% surge from the present price of $4.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.0216 | $0.1316 | $0.0623 | -99.49% |
| February, 2026 | $0.2801 | $0.1208 | $0.1802 | -93.41% |
| March, 2026 | $0.1312 | $0.3098 | $0.3291 | -96.91% |
| April, 2026 | $0.4938 | $0.3784 | $0.487 | -88.38% |
| May, 2026 | $0.2393 | $0.2858 | $0.3817 | -94.37% |
| June, 2026 | $0.5742 | $0.5769 | $0.5449 | -86.49% |
| July, 2026 | $0.2915 | $0.3954 | $0.4638 | -93.14% |
| August, 2026 | $0.4237 | $0.3616 | $0.4314 | -90.03% |
| September, 2026 | $0.3324 | $0.3663 | $0.3931 | -92.18% |
| October, 2026 | $0.2048 | $0.2269 | $0.2844 | -95.18% |
| November, 2026 | $1.6245 | $0.1951 | $1.0445 | -61.78% |
| December, 2026 | $1.2518 | $1.3418 | $1.3339 | -70.55% |
Mangoceuticals Inc Stock (MGRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Mangoceuticals Inc (MGRX) is $0.8739, with a high forecast of $1.2203 and a low forecast of $0.5276. This indicates an -79.44% decrease from the last price of $4.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.1197 | $1.2497 | $1.2203 | -73.65% |
| February, 2027 | $0.3676 | $0.5276 | $0.5287 | -91.35% |
| March, 2027 | $0.915 | $0.5366 | $0.8563 | -78.47% |
| April, 2027 | $0.7629 | $0.8039 | $0.7134 | -82.05% |
| May, 2027 | $0.8108 | $0.7312 | $0.6423 | -80.92% |
| June, 2027 | $0.6805 | $0.8897 | $0.8887 | -83.99% |
| July, 2027 | $1.076 | $0.9176 | $0.9065 | -74.68% |
| August, 2027 | $0.7189 | $0.7538 | $0.9855 | -83.08% |
| September, 2027 | $0.9913 | $0.8134 | $0.9823 | -76.68% |
| October, 2027 | $0.7682 | $0.7992 | $0.8707 | -81.93% |
| November, 2027 | $0.794 | $0.7176 | $0.7671 | -81.32% |
| December, 2027 | $0.6674 | $0.6864 | $0.7295 | -84.30% |
Mangoceuticals Inc Stock (MGRX) Price Forecast for 2028
In 2028, Mangoceuticals Inc (MGRX) is projected to reach an average price of $1.2987, with a high projection of $2.1886 and a low estimate of $0.4087. This indicates an -69.44% fall from the last price of $4.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.4383 | $0.531 | $0.6039 | -89.69% |
| February, 2028 | $2.36 | $0.4087 | $0.9501 | -44.47% |
| March, 2028 | $2.0465 | $2.2871 | $2.1886 | -51.85% |
| April, 2028 | $2.0137 | $2.0851 | $2.0037 | -52.62% |
| May, 2028 | $1.1002 | $1.2602 | $1.853 | -74.11% |
| June, 2028 | $1.6672 | $1.2488 | $1.3073 | -60.77% |
| July, 2028 | $1.4445 | $1.4652 | $1.5379 | -66.01% |
| August, 2028 | $1.411 | $1.3416 | $1.3138 | -66.80% |
| September, 2028 | $1.5982 | $1.4696 | $1.4482 | -62.40% |
| October, 2028 | $1.4854 | $1.4568 | $1.4254 | -65.05% |
| November, 2028 | $1.1869 | $1.2218 | $1.484 | -72.07% |
| December, 2028 | $1.4322 | $1.2712 | $1.4198 | -66.30% |
Mangoceuticals Inc Stock (MGRX) Price Forecast for 2029
The 2029 price forecast for Mangoceuticals Inc Stock (MGRX) is $1.8328 on average, with a high prediction of $3.0432 and a low estimate of $0.6223. This represents an -56.88% decrease from the previous price of $4.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.1445 | $1.1755 | $1.3683 | -73.07% |
| February, 2029 | $1.1296 | $1.0736 | $1.1027 | -73.42% |
| March, 2029 | $1.0028 | $1.0306 | $1.055 | -76.40% |
| April, 2029 | $0.7748 | $0.7961 | $0.9142 | -81.77% |
| May, 2029 | $3.235 | $0.6223 | $1.8251 | -23.88% |
| June, 2029 | $3.0915 | $3.1214 | $3.0432 | -27.26% |
| July, 2029 | $2.928 | $2.8888 | $2.7897 | -31.11% |
| August, 2029 | $1.8736 | $2.2036 | $2.7871 | -55.92% |
| September, 2029 | $2.0451 | $1.9609 | $1.8018 | -51.88% |
| October, 2029 | $2.0957 | $2.1265 | $2.2196 | -50.69% |
| November, 2029 | $1.8622 | $1.952 | $1.9548 | -56.18% |
| December, 2029 | $2.229 | $2.0495 | $1.9588 | -47.55% |
Mangoceuticals Inc Stock (MGRX) Price Forecast for 2030
Mangoceuticals Inc Stock (MGRX) is expected to reach an average price of $2.3669 in 2030, with a high forecast of $3.8979 and a low forecast of $0.8359. This signifies an -44.31% decrease from the last price of $4.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.0042 | $1.996 | $2.0078 | -52.84% |
| February, 2030 | $1.6517 | $1.8407 | $1.9825 | -61.14% |
| March, 2030 | $1.8972 | $1.6897 | $1.8572 | -55.36% |
| April, 2030 | $1.6586 | $1.7032 | $1.8163 | -60.97% |
| May, 2030 | $1.5077 | $1.4297 | $1.5528 | -64.52% |
| June, 2030 | $1.3312 | $1.3358 | $1.4384 | -68.68% |
| July, 2030 | $1.0291 | $1.0504 | $1.278 | -75.79% |
| August, 2030 | $0.8732 | $0.8359 | $0.9106 | -79.45% |
| September, 2030 | $3.5868 | $4.12 | $3.8979 | -15.60% |
| October, 2030 | $3.7216 | $3.6926 | $3.6037 | -12.43% |
| November, 2030 | $2.9073 | $3.0573 | $3.5705 | -31.59% |
| December, 2030 | $2.5931 | $2.6731 | $2.5242 | -38.99% |
0.00%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):